SCHEMBL30462075

SCHEMBL30462075

COc1cnc(-c2cncnc2OC)nc1N

nearest known ligand 0.40

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ CYP17A1 P05093 1/20 0.40
▸ KMT2A Q03164 1/20 0.39
▸ CYP1A2 P05177 3/20 0.35
▸ CYP3A4 P08684 3/20 0.35
▸ HSD17B10 Q99714 2/20 0.35
▸ ALDH1A1 P00352 1/20 0.35
▸ TDP1 Q9NUW8 1/20 0.35
▸ ALK Q9UM73 1/20 0.35
▸ P2RX3 P56373 6/20 0.34
▸ P2RX2 Q9UBL9 6/20 0.34
▸ CYP2D6 P10635 2/20 0.33
▸ CYP2C19 P33261 2/20 0.33
▸ LMNA P02545 1/20 0.33
▸ ALOX15 P16050 1/20 0.33
▸ CYP2C9 P11712 1/20 0.32
▸ TSHR P16473 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30849073 0.81 KMT2A (0.42) KMT2AALDH1A1P2RX3P2RX2LMNA
SCHEMBL27409677 0.81 KMT2A (0.42) KMT2AALDH1A1P2RX3P2RX2LMNA
SCHEMBL30462068 0.79 CYP1A2 (0.49) CYP17A1KMT2ACYP1A2CYP3A4HSD17B10
SCHEMBL30816550 0.76 AURKA (0.38) CYP17A1CYP1A2CYP3A4HSD17B10ALDH1A1
SCHEMBL21174856 0.72 MKNK1 (0.38) CYP17A1
SCHEMBL30816580 0.71 CYP17A1 (0.39) CYP17A1CYP1A2CYP3A4HSD17B10ALDH1A1
SCHEMBL30816598 0.71 NNMT (0.45) CYP17A1
SCHEMBL20640205 0.71 TGFBR1 (0.39) ALK
SCHEMBL31521747 0.71 CYP17A1 (0.39) CYP17A1CYP1A2CYP3A4HSD17B10ALDH1A1
SCHEMBL5735866 0.70 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4741386-A1 PYRIMIDINE COMPOUND, PREPARATION METHOD THEREFOR AND MEDICAL USE THEREOF Jiangsu Yahong Meditech Co., Ltd. (CN) 2026-05-13 — — EP disclosed
CN-118660872-A Pyrimidine compound, preparation method and medical application thereof 江苏亚虹医药科技股份有限公司 2024-09-17 — — CN disclosed
WO-2023208130-A1 PYRIMIDINE COMPOUND, METHOD FOR PREPARING SAME, AND PHARMACEUTICAL USE THEREOF 江苏亚虹医药科技股份有限公司 2023-11-02 — — WO disclosed
CN-116496252-A Pyrimidine compound, preparation method and medical application thereof 江苏亚虹医药科技股份有限公司 2023-07-28 — — CN disclosed
Send feedback